Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03444961 · ClinicalTrials.gov registry record · NA
Computer-Assisted Rehabilitation Environment Training After Argus Retinal Prosthesis
A NA study of Retinitis Pigmentosa, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
- 1
- Study location
NCT03444961: Completed NA study of Retinitis Pigmentosa, sponsored by The Cleveland Clinic.
NCT03444961 is a NA study of Retinitis Pigmentosa that has completed, run by The Cleveland Clinic. The registered enrollment target is 4 participants, below the 261-participant average among 37 other Retinitis Pigmentosa trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03444961, a NA study of Retinitis Pigmentosa, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the current project is to fill the unmet clinical needs around the objective assessment of visual function and develop outcome-oriented visual rehabilitation approach using the computer assisted rehabilitation environment (CAREN) system for Argus recipients.
Primary Outcome
Obstacle course navigation - time (seconds) to complete an obstacle course (walking forward while navigating over a ramp and curb)
Conditions Studied
Interventions
- DEVICE CAREN system training
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2018-01-30 |
| Est. Completion | 2018-06-20 |
| Phase | NA |
What the finished NCT03444961 record still lists
NCT03444961 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 261-participant average among 37 other Retinitis Pigmentosa trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Retinitis Pigmentosa appearing as the primary indexed condition, and to 1 intervention - of which CAREN system training is the first listed.
NCT03444961 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03444961 about?
NCT03444961 is a clinical study titled "Computer-Assisted Rehabilitation Environment Training After Argus Retinal Prosthesis". The goal of the current project is to fill the unmet clinical needs around the objective assessment of visual function and develop outcome-oriented visual rehabilitation approach using the computer assisted rehabilitation environment (CAREN) system for Argus recipients.
What is the current status of trial NCT03444961?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2018-01-30. Estimated completion is 2018-06-20.
What conditions does trial NCT03444961 study?
This clinical trial studies the following conditions: Retinitis Pigmentosa.
What interventions are being tested in trial NCT03444961?
The interventions under investigation include: CAREN system training (DEVICE).
Who is sponsoring clinical trial NCT03444961?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03444961 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retinitis Pigmentosa
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03444961's enrollment target sits among peer trials
4 37th of 37 the lowest of 37 other Retinitis Pigmentosa trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Retinitis Pigmentosa trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stem Cell Ophthalmology Treatment Study II
RECRUITING · NA
-
Experimental and Clinical Studies of Retinal Stimulation
RECRUITING · NA
-
Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for Retinitis Pigmentosa
ACTIVE NOT RECRUITING · NA
-
Prospective Natural History Study of Retinitis Pigmentosa
ACTIVE NOT RECRUITING · NA
-
Argus II/ORCAM Device Study
COMPLETED · NA
-
Object Finder for a Retinal Prosthesis
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI